Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) insider Terrie Curran sold 16,851 shares of the firm’s stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $9.11, for a total transaction of $153,512.61. Following the sale, the insider now directly owns 410,784 shares of the […]
Newtyn Management LLC decreased its position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) by 26.9% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 500,000 shares of the company’s stock after selling 183,648 shares during the quarter. Phathom Pharmaceuticals makes up 1.3% of Newtyn […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) shot up 9.4% during trading on Tuesday . The company traded as high as $10.65 and last traded at $10.16. 351,678 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 761,808 shares. The stock had previously closed at $9.29. Analyst […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report)’s share price was up 9.4% on Tuesday . The company traded as high as $10.65 and last traded at $10.16. Approximately 351,678 shares traded hands during mid-day trading, a decline of 54% from the average daily volume of 761,808 shares. The stock had previously closed at $9.29. […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) shot up 9.4% during trading on Tuesday . The company traded as high as $10.65 and last traded at $10.16. 351,678 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 761,808 shares. The stock had previously closed at $9.29. Analyst […]